<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd">
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" width="781px" height="3271px" viewBox="-0.5 -0.5 781 3271" content="&lt;mxfile host=&quot;app.diagrams.net&quot; modified=&quot;2020-06-26T00:00:36.001Z&quot; agent=&quot;5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.116 Safari/537.36&quot; etag=&quot;-G1MvtKxYO5IIySoh9qJ&quot; version=&quot;13.3.4&quot; type=&quot;github&quot;&gt;&lt;diagram id=&quot;8JQaeR7ikDl0GVS66GYh&quot; name=&quot;Page-1&quot;&gt;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&lt;/diagram&gt;&lt;/mxfile&gt;" resource="https://app.diagrams.net/?src=about#HMedeler%2Fhtml%2Fmaster%2Fpdf%2Fsvg%2F155_tuberculose.svg"><defs/><g><rect x="20" y="1760" width="760" height="480" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="2360" width="758" height="910" fill="none" stroke="#000000" pointer-events="all"/><rect x="428" y="2380" width="350" height="120" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 343px; height: 1px; padding-top: 2387px; margin-left: 435px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le <b>suivi </b>comprend :</div><div><ul><li>clinique, RXT, bactério jusqu'à négativation</li><li>vision couleurs mensuel pendant ttt EMB</li><li>bilan hépatique</li><ul><li>arrêt PZA si &gt; 3N</li><li>arrêt PZA et INH si &gt; 6N</li></ul></ul></div></div></div></div></foreignObject><text x="435" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le suivi comprend :...</text></switch></g><rect x="98" y="2380" width="330" height="110" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 323px; height: 1px; padding-top: 2387px; margin-left: 105px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Le bilan <b>pré-thérapeutique</b> comprend :</div><ul><li>NFS, Na<sup>+</sup>, créat, bilan hépato-rénal, uricémie</li><li>séro VIH, VHB, VHC</li><li>examen ophtalmo + vision couleurs (rifampicine)</li><li>recherche grossesse (pyrazinamide)</li></ul></div></div></div></foreignObject><text x="105" y="2399" fill="#000000" font-family="Karla" font-size="12px">Le bilan pré-thérapeutique comprend :...</text></switch></g><rect x="20" y="1190" width="760" height="500" fill="none" stroke="#000000" pointer-events="all"/><rect x="20" y="120" width="760" height="950" fill="none" stroke="#000000" pointer-events="all"/><rect x="0" y="100" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 115px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Introduction</div></div></div></foreignObject><text x="40" y="119" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Introduction</text></switch></g><rect x="90" y="140" width="690" height="250" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 132px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>maladie transmissible liée à <b>Mycobacterium tuberculosis</b> (= BK), parfois M. bovis ou M. africanum<br /></li><li><b>BAAR aérobie stricte</b> à croissance lente et à multiplication intra- et extra-cellulaire</li><li>Localisation <b>pulmonaire </b>dans 75%</li><li>chez l'imD : 50% localisations extra-pulmonaires, 25% disséminé, symptômes plus légers</li><li>France </li><ul><li>faible incidence : 7/100 000/an</li><li>surtout IDF, Mayotte, Guyane, migrants d'Afrique subsaharienne, SDF</li><li>ALD pour 2 ans</li></ul><li>Monde</li><ul><li>10M cas/an avec 1.5M décès/an</li><li>F5 décès par maladie, F2 décès par maladie infectieuse<br /></li><li>6% sont des tuberculoses multi-résistantes (surtout ex-URSS, Chine, Inde)</li></ul><li><span style="font-size: 12px">Le traitement cible 3 <b>populations de BK</b> :</span></li><ul><li><span style="font-size: 12px">extra-cellulaires (95%) : contagiosité et symptômes ; ssb INH, RMP et streptomycine</span></li><li><span style="font-size: 12px">intra-cellulaires quiescents ; ssb PZA et RMP</span></li><li><span style="font-size: 12px">extra-cellulaires dans le caséeum : rechute ; ssb RMP</span></li></ul></ul></div></div></div></foreignObject><text x="72" y="144" fill="black" font-family="Karla" font-size="12px">maladie transmissible liée à Mycobacterium tuberculosis (= BK), parfois M. bovis ou M. africanum...</text></switch></g><rect x="20" y="140" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 150px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">généralités</div></div></div></foreignObject><text x="55" y="154" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">généralités</text></switch></g><rect x="90" y="390" width="690" height="230" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 708px; height: 1px; padding-top: 382px; margin-left: 72px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ol><li style="font-size: 12px"><b>Contamination </b>: inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= <b style="font-size: 12px">foyer primaire</b>)</li><li style="font-size: 12px"><span style="font-size: 12px"><b>Primo-infection</b> (= PIT) souvent asymptomatique (= ITL = infection tuberculeuse latente)</span></li><ul style="font-size: 12px"><li style="font-size: 12px">BK phagocytés puis multipliés dans <b style="font-size: 12px">macrophages </b>alvéolaires puis gagnent le gg hilaire. Le <b>complexe primaire</b> <br style="font-size: 12px" />est l'association foyer primaire + adénopathie, pouvant rester visible en RXT pendant des années</li><li style="font-size: 12px">Dans les semaines qui suivent la PIT : <b>réponse immune</b> avec afflux des monocytes épithélioïdes formant les <b>granulomes </b>giganto-cellulaires avec nécrose caséeuse contenant des bacilles quiescents. </li><li style="font-size: 12px">L'ITL est parfois patente avec AEG, érythème noueux, kérato-conjonctivite phlycténulaire, adn cervicales. </li></ul><li><span style="font-size: 12px"><b>Tuberculose maladie</b> (= TM) : multiplication des BK (pendant ou après ITL)</span></li><ul><li><span style="font-size: 12px">5% des ITL font une TM &lt; 2 ans post-PIT, 5% font une TM &gt; 2 ans post-PIT</span></li><li>fris de TM :</li><ul><li>imD, diabète, InRé</li><li>fragilité : imD, âges extrêmes, malnutrition, précarité</li><li>alcool, tabac, toxicomanie</li></ul></ul></ol><div><span style="color: rgba(0 , 0 , 0 , 0) ; font-family: monospace ; font-size: 0px">%3CmxGraphModel%3E%3Croot%3E%3CmxCell%20id%3D%220%22%2F%3E%3CmxCell%20id%3D%221%22%20parent%3D%220%22%2F%3E%3CmxCell%20id%3D%222%22%20value%3D%22%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B3%26amp%3Bnbsp%3Bpopulations%26amp%3Bnbsp%3Bde%20BK%20sont%20%C3%A0%20cibler%20%3A%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bextra-cellulaires%20(95%25)%20%3A%20contagiosit%C3%A9%20et%20sympt%C3%B4mes%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20INH%2C%20RMP%20et%20streptomycine%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bintra-cellulaires%20quiescents%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20PZA%20et%20RMP%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bfont%20face%3D%26quot%3BKarla%26quot%3B%26gt%3B%26lt%3Bspan%26gt%3Bextra-cellulaires%20dans%20le%20cas%C3%A9eum%20%3A%20rechute%26lt%3B%2Fspan%26gt%3B%26lt%3Bbr%26gt%3B%26lt%3B%2Ffont%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3Bul%26gt%3B%26lt%3Bli%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Bfont-family%3A%20%26amp%3B%2334%3Bkarla%26amp%3B%2334%3B%26quot%3B%26gt%3Bssb%20%C3%A0%20%3A%20RMP%26lt%3B%2Fspan%26gt%3B%26lt%3B%2Fli%26gt%3B%26lt%3B%2Ful%26gt%3B%26lt%3B%2Ful%26gt%3B%22%20style%3D%22text%3Bhtml%3D1%3B%22%20vertex%3D%221%22%20parent%3D%221%22%3E%3CmxGeometry%20x%3D%22120%22%20y%3D%22560%22%20width%3D%22430%22%20height%3D%22120%22%20as%3D%22geometry%22%2F%3E%3C%2FmxCell%3E%3C%2Froot%3E%3C%2FmxGraphModel%3E</span><br /></div></div></div></div></foreignObject><text x="72" y="394" fill="#000000" font-family="Karla" font-size="12px">Contamination : inhalation d'aérosols (gouttelettes de toux) atteignant les alvéoles (= foyer primaire)Primo-infection...</text></switch></g><rect x="20" y="390" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 405px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">histoire naturelle</div></div></div></foreignObject><text x="55" y="409" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">histoire na...</text></switch></g><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" transform="translate(2,3)" opacity="0.25"/><rect x="100" y="0" width="600" height="80" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 598px; height: 1px; padding-top: 40px; margin-left: 101px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font style="font-size: 30px">155 - Tuberculose</font></div></div></div></foreignObject><text x="400" y="44" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">155 - Tuberculose</text></switch></g><rect x="90" y="1210" width="690" height="70" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1202px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>signes cliniques évoluant depuis des semaines ou des mois</li><li>RXT : nodules, infiltrats ou cavités des lobes supérieurs et postérieurs</li><li>contexte évocateur : contage, voyage, CSP, imD</li><li>dès la suspicion, isoler le patient jusqu'à 15 jours de ttt</li></ul></div></div></div></foreignObject><text x="77" y="1214" fill="black" font-family="Karla" font-size="12px">signes cliniques évoluant depuis des semaines ou des moisRXT : nodules, infiltrats ou cavités des lobes supérieurs et...</text></switch></g><rect x="20" y="1210" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1220px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">suspicion</div></div></div></foreignObject><text x="55" y="1224" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">suspicion</text></switch></g><rect x="20" y="1300" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1315px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">diagnostic<br />positif</div></div></div></foreignObject><text x="55" y="1319" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">diagnostic...</text></switch></g><rect x="88" y="1300" width="690" height="240" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1307px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><font><b>3 prélèvements</b> en 24h :<br /><ul><li><font><b>ECBC </b>en mycobactériologie (recherche de BAAR)</font></li><ul><li><font>si le patient ne crache pas, <b>tubage gastrique</b> le matin à jeun avant le lever</font></li></ul><li>si échec (3 prélèvements négatifs)</li><ul><li>fibroscopie bronchique avec aspiration dirigée <b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li></ul><li><span style="font-size: 12px">si miliaire</span></li><ul><li><span style="font-size: 12px">fibroscopie bronchique avec aspiration dirigée </span><b style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">± </b><span style="text-align: center ; color: rgb(32 , 33 , 34) ; background-color: rgb(255 , 255 , 255)">LBA</span></li><li><font color="#202122"><span style="font-size: 12px">hémoc sur milieu isolator</span></font></li><li><font color="#202122"><span style="font-size: 12px">ECBU en mycobactériologie</span></font></li><li><font color="#202122"><span style="font-size: 12px">si leuco-neutropénie : myéloculture</span></font></li></ul><li><span style="color: rgb(32 , 33 , 34)">si extra-pulmonaire :</span><br /></li><ul><li><span style="color: rgb(32 , 33 , 34)">ganglionnaire : ponction ou biopsie-exérèse d'adénopathie accessible</span></li><li><span style="color: rgb(32 , 33 , 34)">neuro-méningée : PL</span></li><li><span style="color: rgb(32 , 33 , 34)">génito-urinaire : ECBU 3 jours de suite</span></li></ul></ul></font></div></div></div></foreignObject><text x="95" y="1319" fill="#000000" font-family="Karla" font-size="12px">3 prélèvements en 24h :...</text></switch></g><rect x="20" y="1540" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1550px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">analyse</div></div></div></foreignObject><text x="55" y="1554" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">analyse</text></switch></g><rect x="90" y="1540" width="690" height="150" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 1532px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 10<sup>3</sup><span> bacilles/mL. Répéter les prélèvements si examen direct négatif (n'élimine pas le diagnostic)</span></li><li><span>anapath : granulome épithélioïde gigantocellulaire avec nécrose caséeuse (très évocateur mais non pathognomonique)</span></li><li>culture sur milieux enrichis</li><ul><li>milieu solide (Löwenstein-Jensen) en 3-4 semaines</li><li>milieu liquide en 10-15 jours mais doit être reconfirmé par examen direct</li></ul><li><span style="font-size: 12px">identification (M. tuberculosis ou atypique) par biochimie, culture ou PCR</span></li><li>ATBg obligatoire (2% de MDR : résistent à RMP et INH)</li></ul></div></div></div></foreignObject><text x="77" y="1544" fill="black" font-family="Karla" font-size="12px">examen direct : recherche BAAR (coloration Ziehl-Neelsen) en qq heures ; positive ssi &gt; 103 bacilles/mL. Répéter les...</text></switch></g><rect x="0" y="1170" width="80" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 1185px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Diagnostic</div></div></div></foreignObject><text x="40" y="1189" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">Diagnostic</text></switch></g><rect x="20" y="620" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 635px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">localisations</div></div></div></foreignObject><text x="60" y="639" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">localisations</text></switch></g><rect x="100" y="620" width="680" height="350" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 627px; margin-left: 107px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les formes <b>pulmonaires </b>représentent <b>75%</b> des cas<br /><ul><li><b>Tuberculose pulmonaire commune</b> (la plus classique)</li><ul><li>pas de st spécifique : signes généraux, respiratoires (voire pleural)</li><li>lésions des segments postérieurs des lobes supérieurs (PO2 plus élevée : BK aérobie strict)</li><li>3 types de lésions pouvant s'associer : nodules, infiltrats et cavernes</li></ul><li><span style="font-size: 12px"><b>Miliaire </b>tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme disséminée, généralisée, évolution svt défavorable : doit être pec rapidement</span></li><li><span style="font-size: 12px">PID micronodulaire en "grains de mil" bilatérale (parfois lésions macro-nodulaires si forme évoluée)</span></li></ul><li><span style="font-size: 12px"><b>Pleurésie </b>tuberculeuse</span></li><ul><li>épanchement exsudatif et lymphocytaire, unilatéral</li><li>examen direct positif dans &lt; 10%, culture (liquide ou biopsie) positive dans &lt; 30%, anapath de biopsies pleurales positives dans &gt; 80%</li></ul><li><span style="font-size: 12px"><b>Pneumonie aigüe</b> tuberculeuse</span></li><ul><li><span style="font-size: 12px">forme aigüe rare : ensemencement massif de BK sur lésion excavée avec inflammation intense</span></li><li><span style="font-size: 12px">RXT : comme PAC avec petites excavations</span></li></ul></ul><div>Les formes <b>extra-pulmonaires</b> représentent <b>25%</b> des cas, peuvent toucher tous les organes, mais surtout :</div><div><ul><li>gg (50% des formes extra-pulmonaires) : surtout cervicale et médiastinale</li><li>ostéo-articulaire : surtout spondylodiscite tuberculeuse (= mal de Pott)</li><li>génito-urinaire</li><li>neuro-méningée</li></ul></div></div></div></div></foreignObject><text x="107" y="639" fill="#000000" font-family="Karla" font-size="12px">Les formes pulmonaires représentent 75% des cas...</text></switch></g><rect x="20" y="970" width="80" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 985px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">vaccin</div></div></div></foreignObject><text x="60" y="989" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">vaccin</text></switch></g><rect x="100" y="970" width="680" height="80" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 693px; height: 1px; padding-top: 962px; margin-left: 87px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risque</li><li>Administration le plus tôt possible</li><li>Pas de test tuberculinique préalable si nourrisson &lt; 3 mois, mais nécessaire jusqu'à 15 ans</li><li>CI si suspicion VIH ou imD (risque <b>BCGite disséminée</b> potentiellement létale)</li></ul></div></div></div></foreignObject><text x="87" y="974" fill="#000000" font-family="Karla" font-size="12px">Le vaccin n'est plus obligatoire depuis 2007, mais conseillé pour les enfants à haut risqueAdministration le plus tô...</text></switch></g><rect x="20" y="2380" width="78" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 76px; height: 1px; padding-top: 2395px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">bilans</div></div></div></foreignObject><text x="59" y="2399" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">bilans</text></switch></g><rect x="20" y="2848" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 2863px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">traitement</div></div></div></foreignObject><text x="55" y="2867" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">traitement</text></switch></g><rect x="88" y="2848" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2855px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">En général 6 mois : <b>quadrithérapie 2 mois</b> puis <b>bithérapie 4 mois<br /></b></div></div></div></foreignObject><text x="95" y="2867" fill="#000000" font-family="Karla" font-size="12px">En général 6 mois : quadrithérapie 2 mois puis bithérapie 4 mois&#xa;</text></switch></g><rect x="20" y="2530" width="88" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 86px; height: 1px; padding-top: 2540px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">médicaments</div></div></div></foreignObject><text x="64" y="2544" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">médicaments</text></switch></g><rect x="0" y="2340" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 2355px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">TM</div></div></div></foreignObject><text x="30" y="2359" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">TM</text></switch></g><path d="M 218 2878 L 215.5 2878 Q 213 2878 213 2888 L 213 2895.5 Q 213 2903 210.5 2903 L 209.25 2903 Q 208 2903 210.5 2903 L 211.75 2903 Q 213 2903 213 2913 L 213 2920.5 Q 213 2928 215.5 2928 L 218 2928" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 268 2878 L 265.5 2878 Q 263 2878 263 2888 L 263 2895.5 Q 263 2903 260.5 2903 L 259.25 2903 Q 258 2903 260.5 2903 L 261.75 2903 Q 263 2903 263 2913 L 263 2920.5 Q 263 2928 265.5 2928 L 268 2928" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,263,2903)" pointer-events="all"/><rect x="218" y="2878" width="40" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2903px; margin-left: 219px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />PZA<br />EMB</div></div></div></foreignObject><text x="238" y="2907" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><rect x="361" y="2878" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2893px; margin-left: 362px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="381" y="2897" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 411 2878 L 408.5 2878 Q 406 2878 406 2885.5 L 406 2889.25 Q 406 2893 403.5 2893 L 402.25 2893 Q 401 2893 403.5 2893 L 404.75 2893 Q 406 2893 406 2900.5 L 406 2904.25 Q 406 2908 408.5 2908 L 411 2908" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,406,2893)" pointer-events="all"/><path d="M 361 2878 L 358.5 2878 Q 356 2878 356 2885.5 L 356 2889.25 Q 356 2893 353.5 2893 L 352.25 2893 Q 351 2893 353.5 2893 L 354.75 2893 Q 356 2893 356 2900.5 L 356 2904.25 Q 356 2908 358.5 2908 L 361 2908" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="88" y="2958" width="680" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 673px; height: 1px; padding-top: 2965px; margin-left: 95px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Si CI PZA : <b>trithérapie 3 mois </b>puis <b>bithérapie 6 mois</b></div></div></div></foreignObject><text x="95" y="2977" fill="#000000" font-family="Karla" font-size="12px">Si CI PZA : trithérapie 3 mois puis bithérapie 6 mois</text></switch></g><rect x="158" y="2988" width="40" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3008px; margin-left: 159px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br />EMB</div></div></div></foreignObject><text x="178" y="3012" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 158 2988 L 155.5 2988 Q 153 2988 153 2998 L 153 3003 Q 153 3008 150.5 3008 L 149.25 3008 Q 148 3008 150.5 3008 L 151.75 3008 Q 153 3008 153 3018 L 153 3023 Q 153 3028 155.5 3028 L 158 3028" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 208 2988 L 205.5 2988 Q 203 2988 203 2998 L 203 3003 Q 203 3008 200.5 3008 L 199.25 3008 Q 198 3008 200.5 3008 L 201.75 3008 Q 203 3008 203 3018 L 203 3023 Q 203 3028 205.5 3028 L 208 3028" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,203,3008)" pointer-events="all"/><rect x="288" y="2988" width="40" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 3003px; margin-left: 289px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">INH<br />RMP<br /></div></div></div></foreignObject><text x="308" y="3007" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">INH...</text></switch></g><path d="M 288 2988 L 285.5 2988 Q 283 2988 283 2995.5 L 283 2999.25 Q 283 3003 280.5 3003 L 279.25 3003 Q 278 3003 280.5 3003 L 281.75 3003 Q 283 3003 283 3010.5 L 283 3014.25 Q 283 3018 285.5 3018 L 288 3018" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 338 2988 L 335.5 2988 Q 333 2988 333 2995.5 L 333 2999.25 Q 333 3003 330.5 3003 L 329.25 3003 Q 328 3003 330.5 3003 L 331.75 3003 Q 333 3003 333 3010.5 L 333 3014.25 Q 333 3018 335.5 3018 L 338 3018" fill="none" stroke="#000000" stroke-miterlimit="10" transform="rotate(180,333,3003)" pointer-events="all"/><path d="M 648 2968 L 648 2967.65 L 658 2967.29 L 668 2967.88 L 678 2968.53 L 688 2967.98 L 698 2967.89 L 708 2968.07 L 718 2968.31 L 728 2967.82 L 738 2968.51 L 748 2968.67 L 758 2968 L 758.17 2968 L 757.75 2976 L 757.88 2984 L 757.78 2992 L 758.05 3000 L 758 3008 L 758 3007.42 L 748 3008.23 L 738 3007.77 L 728 3007.52 L 718 3007.49 L 708 3007.33 L 698 3008.4 L 688 3008.16 L 678 3008.31 L 668 3007.66 L 658 3008.12 L 648 3008 L 647.88 3008 L 648.2 3000 L 648.05 2992 L 648.01 2984 L 648.19 2976 L 648 2968 L 648 2968 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2988px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Les ATB sont à adapter selon l'ATBg</div></div></div></foreignObject><text x="703" y="2992" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">Les ATB sont à ada...</text></switch></g><rect x="108" y="2530" width="670" height="290" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 663px; height: 1px; padding-top: 2537px; margin-left: 115px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div>Les anti-tuberculeux utilisés en <b>1e intention</b> sont :</div><ul><li><b>Isoniazide </b>= INH (RIMIFON)</li><ul><li>EI : <b>hépatite</b>, polynévrite sst-mot si carence B6</li></ul><li><b>Rifampicine </b><span>= RMP (RIMACTAN, RIFADINE)</span><br /></li><ul><li><b>colore en orange</b><span> les larmes, sperme et urines (normal mais prévenir)</span><br /></li><li>intéractions : anticoagulants oraux, pilule oestro-progestative (à changer car rend inefficace), inhibiteurs de protéase, CTC, digitaliques</li></ul><li><span style="font-size: 12px"><b>Pyrazinamine </b>= PZA (PIRILENE)</span></li><ul><li><span style="font-size: 12px">CI si InHep ou InRé, déconseillée si grossesse</span></li><li><span style="font-size: 12px">EI : <b>cytolyse hépatique</b> (plus tardif que INH), hyperuricémie svt ast, rash vasomoteur</span></li></ul><li><span style="font-size: 12px"><b>Ethambutol</b> = EMB (MYAMBUTOL, DEXAMBUTOL)</span></li><ul><li><span style="font-size: 12px">EI : <b>névrite optique rétrobulbaire</b> (fris : posologie élevée, éthylisme chronique, InRé)</span></li></ul></ul><div>En <b>2e intention</b>, on peut utiliser des <b>aminosides </b>(streptomycine et amikacine). Les EI principaux sont les toxicités rénale et auditive. Les <b>FQ </b>sont aussi utilisables en 2e intention</div></div></div></div></foreignObject><text x="115" y="2549" fill="black" font-family="Karla" font-size="12px">Les anti-tuberculeux utilisés en 1e intention sont :...</text></switch></g><path d="M 428 2500 L 428 2380" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 648 2848 L 648 2848.32 L 658 2848.27 L 668 2847.86 L 678 2847.82 L 688 2848.6 L 698 2848.24 L 708 2848.54 L 718 2847.46 L 728 2847.46 L 738 2848.43 L 748 2848.43 L 758 2848 L 758.08 2848 L 758.32 2858 L 758.62 2868 L 757.45 2878 L 757.44 2888 L 758 2898 L 758 2897.51 L 748 2898.14 L 738 2897.33 L 728 2898.64 L 718 2897.55 L 708 2898.35 L 698 2898.11 L 688 2898.04 L 678 2897.37 L 668 2897.49 L 658 2898.49 L 648 2898 L 647.33 2898 L 647.91 2888 L 648.53 2878 L 647.85 2868 L 648.72 2858 L 648 2848 L 648 2848 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2873px; margin-left: 649px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si neuro-méningée : durée de 9-12 mois</div></div></div></foreignObject><text x="703" y="2877" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si neuro-méningée...</text></switch></g><path d="M 638 2908 L 638 2907.62 L 648 2907.89 L 658 2907.76 L 668 2908.43 L 678 2908.53 L 688 2907.49 L 698 2907.65 L 708 2907.27 L 718 2907.77 L 728 2907.8 L 738 2908.68 L 748 2908.24 L 758 2908 L 758.46 2908 L 758.19 2918 L 758.71 2928 L 757.7 2938 L 758.75 2948 L 758 2958 L 758 2957.8 L 748 2958.56 L 738 2958.25 L 728 2957.93 L 718 2958.04 L 708 2957.68 L 698 2958.71 L 688 2957.34 L 678 2957.34 L 668 2957.84 L 658 2957.85 L 648 2957.64 L 638 2958 L 637.81 2958 L 637.64 2948 L 638.34 2938 L 638.7 2928 L 638.51 2918 L 638 2908 L 638 2908 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 118px; height: 1px; padding-top: 2933px; margin-left: 639px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">si miliaire très sévère : ajout CTC</div></div></div></foreignObject><text x="698" y="2937" fill="#000000" font-family="Pangolin" font-size="12px" text-anchor="middle">si miliaire très sév...</text></switch></g><rect x="90" y="1780" width="690" height="170" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 683px; height: 1px; padding-top: 1787px; margin-left: 97px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: black; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px">Les 2 moyens de dépister les ITL sont :</div><div style="font-size: 12px"><ul style="font-size: 12px"><li style="font-size: 12px"><b style="font-size: 12px">IDR </b>(= intradermoréaction) = RCT (= réaction cutanée tuberculinique) </li><ul style="font-size: 12px"><li style="font-size: 12px">interprétation difficile si vaccin BCG &lt; 10 ans car se positive avec M. bovis</li><li style="font-size: 12px">lecture à 72h : IDR positive si induration &gt; 5 mm</li><li style="font-size: 12px">suspicion ITL si <b style="font-size: 12px">&gt; 10 mm sans BCG</b> ou augmentation<b style="font-size: 12px"> 10 mm entre 2 IDR en 3 mois</b></li></ul><li style="font-size: 12px"><b style="font-size: 12px">IGRA </b>(détection de production d'<span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">IFN</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">-</span><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">γ) par prise de sang</span></li><ul style="font-size: 12px"><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">meilleure VPP que l'IDR (osef BCG)</span></li><li style="font-size: 12px"><span style="font-size: 12px ; background-color: rgb(255 , 255 , 255)">résultats après qq jours</span></li></ul></ul></div></div></div></div></foreignObject><text x="97" y="1799" fill="black" font-family="Karla" font-size="12px">Les 2 moyens de dépister les ITL sont :...</text></switch></g><path d="M 598 1210 L 598 1210.27 L 608 1210.46 L 618 1210.08 L 628 1210.02 L 638 1209.85 L 648 1209.55 L 658 1210.56 L 668 1210.12 L 678 1209.41 L 688 1209.47 L 698 1209.4 L 708 1210.26 L 718 1209.85 L 728 1209.39 L 738 1209.45 L 748 1210.34 L 758 1210 L 758.14 1210 L 757.85 1220 L 757.39 1230 L 758.37 1240 L 758.39 1250 L 758.16 1260 L 758 1270 L 758 1269.3 L 748 1269.38 L 738 1269.56 L 728 1269.28 L 718 1269.48 L 708 1270.2 L 698 1269.37 L 688 1269.35 L 678 1270.73 L 668 1269.51 L 658 1270.47 L 648 1269.86 L 638 1269.41 L 628 1270.24 L 618 1269.5 L 608 1269.8 L 598 1270 L 597.27 1270 L 597.38 1260 L 597.92 1250 L 598.74 1240 L 598.18 1230 L 597.43 1220 L 598 1210 L 598 1210 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 158px; height: 1px; padding-top: 1240px; margin-left: 600px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"><span>Déclaration ARS :</span></div>- ITL d'enfant &lt; 15 ans<br />- TM confirmée ou suspectée</div></div></div></foreignObject><text x="600" y="1244" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration ARS :- ITL d'e...</text></switch></g><rect x="0" y="1740" width="60" height="30" fill="#b0e3e6" stroke="#0e8088" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1755px; margin-left: 1px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ITL</div></div></div></foreignObject><text x="30" y="1759" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ITL</text></switch></g><rect x="20" y="1780" width="70" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 1790px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">dépistage</div></div></div></foreignObject><text x="55" y="1794" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">dépistage</text></switch></g><rect x="228" y="1950" width="60" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 58px; height: 1px; padding-top: 1960px; margin-left: 229px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">contact</div></div></div></foreignObject><text x="258" y="1964" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">contact</text></switch></g><path d="M 243 1970 L 210.64 1987.03" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 205.99 1989.48 L 210.55 1983.12 L 210.64 1987.03 L 213.81 1989.32 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 273 1970 L 294.88 1986.21" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 299.1 1989.33 L 291.39 1987.98 L 294.88 1986.21 L 295.56 1982.36 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 180.02 2020 L 180.15 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 180.16 2138.88 L 176.65 2131.89 L 180.15 2133.63 L 183.65 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="130" y="1990" width="100" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 2005px; margin-left: 132px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- enfant &lt; 2 ans<br />- imD sévère</div></div></div></foreignObject><text x="132" y="2009" fill="#000000" font-family="Karla" font-size="12px">- enfant &lt; 2 ans...</text></switch></g><rect x="130" y="2140" width="380" height="70" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe center; width: 378px; height: 1px; padding-top: 2147px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CHIMIOPROPHYLAXIE</div></div></div></foreignObject><text x="320" y="2159" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">CHIMIOPROPHYLAXIE</text></switch></g><rect x="280" y="1990" width="80" height="50" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 78px; height: 1px; padding-top: 2015px; margin-left: 282px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">- répété<br />- rapproché<br />- fragile</div></div></div></foreignObject><text x="282" y="2019" fill="#000000" font-family="Karla" font-size="12px">- répété...</text></switch></g><rect x="370" y="1975" width="190" height="60" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 188px; height: 1px; padding-top: 2005px; margin-left: 372px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px">- avant ttt <span style="color: rgb(34 , 34 , 34) ; background-color: rgb(255 , 255 , 255) ; font-size: 12px">anti-TNFα<br /></span>- bilan VIH<br />- pro. santé<br />- migrants &lt; 15 ans forte endémie<br /></font></div></div></div></foreignObject><text x="372" y="2009" fill="#000000" font-family="Karla" font-size="12px">- avant ttt anti-TNFα...</text></switch></g><path d="M 320 2090 L 320 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2138.88 L 316.5 2131.88 L 320 2133.63 L 323.5 2131.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="280" y="2060" width="80" height="30" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 78px; height: 1px; padding-top: 2075px; margin-left: 281px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IDR ou IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="320" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IDR ou IGRA&#xa;</text></switch></g><path d="M 320 2040 L 320 2053.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 320 2058.88 L 316.5 2051.88 L 320 2053.63 L 323.5 2051.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><path d="M 465 2035 L 465 2058.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465 2063.88 L 461.5 2056.88 L 465 2058.63 L 468.5 2056.88 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="340" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 341px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">bithérapie 3-4 mois<br /><div><span style="font-size: 14px ; font-weight: 400 ; background-color: rgb(255 , 255 , 255)">(INH + RMP)</span></div></div></div></div></foreignObject><text x="425" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">bithérapie 3-4 mois...</text></switch></g><rect x="300" y="2170" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2180px; margin-left: 301px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; "><span style="font-weight: normal">ou</span></div></div></div></foreignObject><text x="320" y="2184" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">ou</text></switch></g><rect x="130" y="2170" width="170" height="40" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 168px; height: 1px; padding-top: 2190px; margin-left: 131px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; font-weight: bold; white-space: normal; word-wrap: normal; ">monothérapie 6-9 mois<br /><span style="font-weight: normal">(INH)</span></div></div></div></foreignObject><text x="215" y="2194" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle" font-weight="bold">monothérapie 6-9 mois...</text></switch></g><rect x="125" y="2065" width="110" height="30" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 108px; height: 1px; padding-top: 2080px; margin-left: 126px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">ne pas attendre la<br />confirmation d'ITL</div></div></div></foreignObject><text x="180" y="2084" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ne pas attendre la...</text></switch></g><path d="M 465.02 2085 L 465.14 2133.63" fill="none" stroke="#000000" stroke-miterlimit="10" pointer-events="stroke"/><path d="M 465.16 2138.88 L 461.64 2131.89 L 465.14 2133.63 L 468.64 2131.87 Z" fill="#000000" stroke="#000000" stroke-miterlimit="10" pointer-events="all"/><rect x="445" y="2065" width="40" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 38px; height: 1px; padding-top: 2075px; margin-left: 446px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div><b>IGRA</b><br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="465" y="2079" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">IGRA&#xa;</text></switch></g><rect x="396" y="1950" width="100" height="20" fill="none" stroke="#000000" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 98px; height: 1px; padding-top: 1960px; margin-left: 398px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="text-align: center"></div><font style="font-size: 12px"><b>autres situations</b><br /></font></div></div></div></foreignObject><text x="398" y="1964" fill="#000000" font-family="Karla" font-size="12px">autres situation...</text></switch></g><rect x="377" y="2100" width="210" height="20" fill="#ffffff" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 208px; height: 1px; padding-top: 2110px; margin-left: 378px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><div style="font-size: 12px"></div><font style="font-size: 12px"><div></div>ssi &lt; 18 ans, imD ou ITL récent (&lt; 1 an)<br style="font-size: 12px" /></font></div></div></div></foreignObject><text x="482" y="2114" fill="#000000" font-family="Karla" font-size="12px" text-anchor="middle">ssi &lt; 18 ans, imD ou ITL récent (&lt;...</text></switch></g><rect x="20" y="1950" width="50" height="20" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 48px; height: 1px; padding-top: 1960px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">CAT</div></div></div></foreignObject><text x="45" y="1964" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">CAT</text></switch></g><rect x="20" y="3060" width="70" height="30" fill="#f5f5f5" stroke="#666666" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 68px; height: 1px; padding-top: 3075px; margin-left: 21px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #333333; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">cas particuliers</div></div></div></foreignObject><text x="55" y="3079" fill="#333333" font-family="Karla" font-size="12px" text-anchor="middle">cas particu...</text></switch></g><rect x="90" y="3060" width="690" height="210" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe flex-start; justify-content: unsafe flex-start; width: 703px; height: 1px; padding-top: 3052px; margin-left: 77px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Karla; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; "><ul><li>grossesse</li><ul><li>supplémenter en B6 (INH), K1 (RMP)</li><li>en France, PZA déconseillée pendant grossesse et allaitement</li></ul><li>InRé</li><ul><li>clairance &gt; 30 : ttt normal</li><li>clairance = 15-30 : diminuer EMB, PZA</li><li>clairance &lt; 15 ou dialyse : diminuer INH, EMB, PZA</li></ul><li><span style="font-size: 12px">InHep</span></li><ul><li><span style="font-size: 12px">transaminases = 3-6N asymptomatique : arrêt PZA (peut être repris si retour à la normale)</span></li><li><span style="font-size: 12px">transaminases &gt; 6N ou symptomatique : arrêt INH et PZA voire du ttt antituberculeux</span></li></ul><li><span style="font-size: 12px">tuberculoses multi-résistantes</span></li><ul><li><span style="font-size: 12px">MDR (VS INH et RMP) : représente 2% des tuberculoses en France, ttt de 2e intention (aminosides, FQ)</span></li><li><span style="font-size: 12px">XDR (MDR + FQ + ...) : très mortelle mais exceptionnelle en France</span></li></ul></ul></div></div></div></foreignObject><text x="77" y="3064" fill="#000000" font-family="Karla" font-size="12px">grossesse...</text></switch></g><path d="M 603 1310 L 603 1310.26 L 613 1309.35 L 623 1309.93 L 633 1310.67 L 643 1310 L 653 1310.28 L 663 1310.29 L 673 1310.46 L 683 1310.27 L 693 1309.3 L 703 1310.43 L 713 1310.43 L 723 1310.03 L 733 1309.76 L 743 1309.42 L 753 1310 L 752.56 1310 L 752.68 1320 L 752.35 1330 L 752.71 1340 L 753.69 1350 L 753 1360 L 753 1359.39 L 743 1360.25 L 733 1359.61 L 723 1360.42 L 713 1359.95 L 703 1359.59 L 693 1360.1 L 683 1359.25 L 673 1360.5 L 663 1360.27 L 653 1359.97 L 643 1359.88 L 633 1360.42 L 623 1360.07 L 613 1359.78 L 603 1360 L 602.34 1360 L 602.63 1350 L 602.55 1340 L 602.42 1330 L 603.51 1320 L 603 1310 L 603 1310 Z Z" fill="none" stroke="#000000" stroke-linejoin="round" stroke-linecap="round" stroke-miterlimit="10" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe flex-start; width: 148px; height: 1px; padding-top: 1335px; margin-left: 605px;"><div style="box-sizing: border-box; font-size: 0; text-align: left; "><div style="display: inline-block; font-size: 12px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">Déclaration CLAT nominatif pour enquête autour du cas<br /><div style="text-align: center"></div></div></div></div></foreignObject><text x="605" y="1339" fill="#000000" font-family="Pangolin" font-size="12px">Déclaration CLAT nominati...</text></switch></g><rect x="668" y="1280" width="20" height="20" fill="none" stroke="none" pointer-events="all"/><g transform="translate(-0.5 -0.5)"><switch><foreignObject style="overflow: visible; text-align: left;" pointer-events="none" width="100%" height="100%" requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"><div xmlns="http://www.w3.org/1999/xhtml" style="display: flex; align-items: unsafe center; justify-content: unsafe center; width: 18px; height: 1px; padding-top: 1290px; margin-left: 669px;"><div style="box-sizing: border-box; font-size: 0; text-align: center; "><div style="display: inline-block; font-size: 19px; font-family: Pangolin; color: #000000; line-height: 1.2; pointer-events: all; white-space: normal; word-wrap: normal; ">+</div></div></div></foreignObject><text x="678" y="1296" fill="#000000" font-family="Pangolin" font-size="19px" text-anchor="middle">+</text></switch></g></g><switch><g requiredFeatures="http://www.w3.org/TR/SVG11/feature#Extensibility"/><a transform="translate(0,-5)" xlink:href="https://desk.draw.io/support/solutions/articles/16000042487" target="_blank"><text text-anchor="middle" font-size="10px" x="50%" y="100%">Viewer does not support full SVG 1.1</text></a></switch></svg>